Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Immunobiology

Effect of extended immunosuppressive drug treatment on B cell vs T cell reconstitution in pediatric bone marrow transplant recipients

Abstract

Allogeneic bone marrow transplantation (BMT) is an effective therapy for a variety of malignancies and blood disorders, but rarely serves as a frontline treatment because of numerous, potential complications. Important and frequent complications relate to the profound immunosuppression that inevitably occurs during the first several months following treatment. To better elucidate and subsequently improve immune reconstitution, we examined T and B cell subsets among 43 pediatric BMT recipients in a retrospective study. We found that the relative numbers of T cells and B cells (T:B ratios) were discordant and highly variable among patients at day 100 after BMT. Further investigation of BMT parameters identified a strong correlation between T:B ratios and immunosuppressive drug treatments, providing an explanation for variable lymphocyte reconstitution profiles. Results suggest that: (1) immunosuppressive therapy inhibits B cell expansion more strongly than T cell expansion following BMT; (2) WBC and absolute lymphocyte counts fail to reveal profound B cell immunodeficiencies in some BMT patients; and (3) routine analyses of T:B ratios serve to identify patients warranting close follow-up and extended supportive immunotherapy. Bone Marrow Transplantation (2001) 28, 573–580.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Meyers JD, Flournoy N, Thomas ED . Risk factors for cytomegalovirus infection after human marrow transplantation J Infect Dis 1986 153: 478–488

    Article  CAS  PubMed  Google Scholar 

  2. Zutter MM, Martin PJ, Sale GE et al. Epstein–Barr virus lymphoproliferation after bone marrow transplantation Blood 1988 72: 520–529

    CAS  PubMed  Google Scholar 

  3. Wingard JR . Advances in the management of infectious complications after bone marrow transplantation Bone Marrow Transplant 1990 6: 371–383

    CAS  PubMed  Google Scholar 

  4. Wilson A, Sharp M, Koropchak CM et al. Subclinical varicella-zoster virus viremia, herpes zoster, and T lymphocyte immunity to varicella-zoster viral antigens after bone marrow transplantation J Infect Dis 1992 165: 119–126

    Article  CAS  PubMed  Google Scholar 

  5. Hongeng S, Krance RA, Bowman LC et al. Outcomes of transplantation with matched-sibling and unrelated-donor bone marrow in children with leukaemia Lancet 1997 350: 767–771

    Article  CAS  PubMed  Google Scholar 

  6. Lum LG . Immune recovery after bone marrow transplantation Hematol/Oncol Clin N Am 1990 4: 659–675

    Article  CAS  Google Scholar 

  7. Atkinson K . Reconstruction of the haemopoietic and immune systems after marrow transplantation Bone Marrow Transplant 1990 5: 209–226

    CAS  PubMed  Google Scholar 

  8. Buckley RH, Schiff SE, Sampson HA et al. Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation J Immunol 1986 136: 2398–2407

    CAS  PubMed  Google Scholar 

  9. Lamb LS, Gee AP, Henslee-Downey PJ et al. Phenotypic and functional reconstitution of peripheral blood lymphocytes following T cell-depleted bone marrow transplantation from partially mismatched related donors Bone Marrow Transplant 1998 21: 461–471

    Article  PubMed  Google Scholar 

  10. Foot ABM, Potter MN, Donaldson C et al. Immune reconstitution after BMT in children Bone Marrow Transplant 1993 11: 7–13

    CAS  PubMed  Google Scholar 

  11. Heslop HE, Benaim E, Brenner MK et al. Response of steroid-resistant graft-versus-host disease to lymphoblast antibody CBL1 Lancet 1995 346: 805–806

    Article  CAS  PubMed  Google Scholar 

  12. Rousseeuw P, Leroy AM . Robust regression and outlier detection John Wiley and Sons: New York 1987

    Book  Google Scholar 

  13. Ku G, Witte ON . Corticosteroid-resistant bone marrow-derived B lymphocyte progenitor for long term in vitro cultures J Immunol 1986 137: 2802–2807

    CAS  PubMed  Google Scholar 

  14. Denis KA, Witte ON . In vitro development of B lymphocytes from long-term cultured precursor cells Proc Natl Acad Sci USA 1986 83: 441–445

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Cupps TR, Edgar LC, Thomas CA, Fauci AS . Multiple mechanisms of B cell immunoregulation in man after administration of in vivo corticosteroids J Immunol 1984 132: 170–175

    CAS  PubMed  Google Scholar 

  16. Storek J, Witherspoon RP, Webb D, Storb R . Lack of B cell precursors in marrow transplant recipients with chronic graft-versus-host disease Am J Hematol 1996 52: 82–89

    Article  CAS  PubMed  Google Scholar 

  17. Rencher SD, Houston JA, Lockey TD, Hurwitz JL . Eliminating graft-versus-host potential from T cell immunotherapeutic populations Bone Marrow Transplant 1996 18: 415–420

    CAS  PubMed  Google Scholar 

  18. Slobod KS, Benaim E, Woodruff L et al. T cell immunotherapeutic populations control viral infections in bone marrow transplant recipients Immunol Res 2001 (in press)

  19. Slobod KS, Hurwitz JL . Adoptive Immunotherapy Pediatr Infect Dis J 1999 18: 467–468

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This work was funded in part by grants from the National Institutes of Health, National Cancer Institute: P30-CA21765 and RO1-CA57419, The Assisi Foundation, and the American Lebanese Syrian Associated Charities. We thank our clinical colleagues Drs Malcolm K Brenner, Robert Krance and Helen E Heslop for helping care for patients and initiating lymphocyte analyses. We thank Xin Tong of the Biostatistics and Epidemiology Department of St Jude Children's Research Hospital for assistance with statistical calculations.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

D'Costa, S., Slobod, K., Benaim, E. et al. Effect of extended immunosuppressive drug treatment on B cell vs T cell reconstitution in pediatric bone marrow transplant recipients. Bone Marrow Transplant 28, 573–580 (2001). https://doi.org/10.1038/sj.bmt.1703185

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1703185

Keywords

Search

Quick links